Maxigen Biotech Inc. reported consolidated revenues results for the month and year to date ended November 2022. On a consolidated basis, revenues for November 2022 were approximately TWD 52.287 million, an increase of 20.46% over the same period in 2021.

Revenues for January through November 2022 totaled TWD 542.699 million, an increase of 15.25% compared to the TWD 470.904 million for the same period in 2021.